Survival Up With Tebentafusp in Metastatic Uveal Melanoma
Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.